New Pixantrone Data Presented At Meetings At American Society Of Hematology Conference
Links shared publicly online about this topic.
- 672total visits
New Pixantrone Data Presented At Meetings At American Society Of Hematology Conference
Cell Therapeutics, Inc. (the Company) (Nasdaq and MTA: CTIC) announced new pixantrone end of study (EOS) follow up results from the Company's pivotal phase III PIX301 trial, which results form
View full resource at medicalnewstoday.com
Tags: Cancer, Leukemia, Lymphoma
Most Recently Shared on December 8, 2010 at 9:05 am By:
New Pixantrone Data Presented At Meetings At American Society Of Hematology Conference http://mnt.to/3NG9 #pharma #pharmaceutical
Also Shared By:
Advertisement
MNT Med Conferences
@mnt_conferences
New Pixantrone Data Presented At Meetings At American Society Of Hematology Conference http://mnt.to/3NG9 #medicalconferences
1 year ago...